Posted by Michael Wonder on 28 Nov 2021
New treatment for Australians with leukaemia
28 November 2021 - From 1 December 2021, Australians with acute myeloid leukaemia will have access to a new treatment option on the Pharmaceutical Benefits Scheme.
The Morrison Government is expanding the list of Venclexta (venetoclax) for the treatment of acute myeloid leukaemia, for use in combination with azacitidine.
